Menu Expand
Practical Pulmonary Pathology: A Diagnostic Approach E-Book

Practical Pulmonary Pathology: A Diagnostic Approach E-Book

Kevin O. Leslie | Mark R. Wick

(2017)

Additional Information

Book Details

Abstract

Part of the in-depth and practical Pattern Recognition series, Practical Pulmonary Pathology, 3rd Edition, helps you accurately identify and interpret neoplastic and non-neoplastic diseases of the lungs by using a pattern-based approach. Leading diagnosticians in pulmonary pathology guide you from a histological pattern, through the appropriate work-up, around the pitfalls, and to the best diagnosis. Superb, full-color illustrations capture key pathological patterns for a full range of common and rare conditions, and a "visual index" at the beginning of the book directs you to the exact location of in-depth diagnostic guidance.

A user-friendly design color-codes patterns to specific entities, and key points are summarized in tables, charts, and graphs so you can quickly and easily find what you are looking for.

  • Sweeping content updates keep you at the forefront of recent findings regarding pulmonary hypertension, pediatric lung disease, and all major neoplastic and non-neoplastic diseases of the lung.
  • A new chapter on Pulmonary Function Testing for Pathologists brings you up to date with relevant aspects of these key tests.
  • Improved pattern call-outs are now linked directly within the chapter, reinforcing the patterns for more efficient and complete understanding.

Table of Contents

Section Title Page Action Price
Front Cover cover
Inside Front Cover ifc1
Half title page i
Pattern Recognition Series ii
Practical Pulmonary Pathology: A Diagnostic Approach iii
Copyright Page iv
Dedication v
Contributors vii
Series Preface ix
Preface xi
Table Of Contents xiii
Pattern-Based Approach to Diagnosis xv
Pattern 1 Acute Lung Injury xviii
Pattern 2 Fibrosis xx
Pattern 3 Chronic Cellular Infiltrates xxii
Pattern 4 Alveolar Filling xxiv
Pattern 5 Nodules xxvi
Pattern 6 Nearly Normal Lung xxix
1 Lung Anatomy 1
Development and Gross Anatomy 1
Airway Development 1
Pleura 1
Lung Lobes 1
Microscopic Anatomy 5
Conducting Airways 5
Trachea 5
Bronchi 5
Bronchioles 5
Airway Mucosal Neuroendocrine Cells 5
Airway-Associated Lymphoid Tissue 6
Epithelial Basement Membrane 7
Smooth Muscle of the Airways 7
Acinus 7
Alveoli 8
Alveolar Walls 8
Alveolar Macrophages 8
Pulmonary Arteries 8
Pulmonary Veins 9
Bronchial Arteries 10
Pulmonary Lymphatics 11
Other Pulmonary Lymphoid Tissue 11
Lymphoid Aggregates 11
Dendritic Cells 11
References 13
Multiple Choice Questions 14.e1
2 Pulmonary Function Testing for Pathologists 15
Lung Volumes 15
Tools to Measure Volumes 16
Interpretation of Lung Volumes 17
Flows 17
Airway Resistance 17
Respiratory Muscle Strength 17
Diffusion Capacity 18
Summary 19
References 19
Multiple Choice Questions 20.e1
Case 1 20.e3
3 Optimal Processing of Diagnostic Lung Specimens 21
Specimens Obtained Through the Flexible Bronchoscope 21
Endobronchial Biopsy 21
Transbronchial Biopsy 22
Cryobiopsy 25
Bronchial Brushings 26
Bronchial Washings and Bronchoalveolar Lavage 26
Transbronchial Fine-Needle Aspiration 28
Endobronchial Ultrasound–Guided Biopsy 29
Rigid Bronchoscopy 29
Specimens Obtained by Transthoracic Needle Biopsy and Aspiration 29
Thoracentesis 29
Closed Pleural Biopsy 29
Transthoracic Fine-Needle Core Aspiration and Biopsy of the Lung 29
Specimens Obtained by Thoracoscopy 30
Specimen Processing 30
Conclusion 31
References 33
Multiple Choice Questions 34.e1
Case 1 34.e2
Transbronchial biopsy with sponge artifact (eSlide 3.1) 34.e2
Case 2 34.e3
Cryobiopsy with diagnosable interstitial lung disease (eSlide 3.2) 34.e3
Case 3 34.e3
Endobronchial ultrasound–guided fine-needle aspiration with adenocarcinoma (eSlide 3.3) 34.e3
Case 4 34.e3
Needle biopsy with mucinous adenocarcinoma (eSlide 3.4) 34.e3
Case 5 34.e3
Poorly processed video-assisted thoracic surgery biopsy with crush and atelectasis (eSlide 3.5) 34.e3
4 Computed Tomography of Diffuse Lung Diseases and Solitary Pulmonary Nodules 35
Foundations 35
Living With X-Rays and Working With Computed Tomography 35
X-Rays and Computed Tomography 35
Computed Tomography, Spiral Computed Tomography, and High-Resolution Computed Tomography 35
Terminology 36
Lung Anatomy 37
Arteries, Veins, and Bronchi 37
Secondary Lobule 38
Special Techniques 38
Increasing Visibility 38
Multiplanar Reformation. 38
Curved Multiplanar Reformation. 39
Increasing Ambience 39
Maximum Intensity Projection. 39
Minimum Intensity Projection. 39
Volume Rendering. 40
Prone and Expiratory Computed Tomography 40
Diffuse Lung Diseases 40
Elementary Lesions 40
Patterns 40
Septal Pattern 41
Definition 41
High-Resolution Computed Tomography Signs 41
Subsets 43
Subset Smooth 43
Interstitial Hydrostatic Pulmonary Edema. 43
Lymphangitic Carcinomatosis. 45
Venoocclusive Disease. 46
Erdheim-Chester Disease. 46
Subset Nodular 46
Diffuse Interstitial Amyloidosis. 47
Fibrotic Pattern 48
Definition 48
High-Resolution Computed Tomography Signs 48
Subsets 49
Subset Usual Interstitial Pneumonia 49
Asbestosis. 49
Chronic Hypersensitivity Pneumonitis. 50
Idiopathic Usual Interstitial Pneumonia–Clinical Idiopathic Pulmonary Fibrosis. 52
Subset Fibrotic Nonspecific Interstitial Pneumonia 53
Idiopathic Fibrotic Nonspecific Interstitial Pneumonia. 53
Subset Tug-of-War 54
Sarcoidosis, Chronic. 54
Pleuroparenchymal Fibroelastosis. 56
Subset Bronchocentric Fibrosis 56
Airway-Centered Interstitial Fibrosis. 56
Nodular Pattern 57
Definition 57
High-Resolution Computed Tomography Signs 57
Subsets 58
Subset Centrilobular 58
Follicular Bronchiolitis. 59
Subacute Hypersensitivity Pneumonitis. 59
Respiratory Bronchiolitis–Interstitial Lung Disease. 60
Subset Lymphatic 61
Sarcoidosis. 62
Lymphoid Interstitial Pneumonia. 62
Silicosis and Coal Worker’s Pneumoconiosis. 63
Subset Random 64
Hematogenous Metastases. 64
Miliary Tuberculosis. 65
Alveolar Pattern 66
Definition 66
High-Resolution Computed Tomography Signs 67
Subsets 68
Subset Acute 68
Acute Interstitial Pneumonia/Acute Respiratory Distress Syndrome. 68
Acceleration (Acute Exacerbation) of Fibrosing Diseases. 69
Diffuse Alveolar Hemorrhage. 69
Hydrostatic Pulmonary Edema. 70
Infectious Diseases. 70
Subset Chronic 72
Adenocarcinoma. 72
Chronic Eosinophilic Pneumonia. 73
Desquamative Interstitial Pneumonia. 74
Infectious and Inflammatory Diseases. 74
Mucosa-Associated Lymphoid Tissue Lymphoma. 75
Cellular Nonspecific Interstitial Pneumonia. 75
Organizing Pneumonia. 76
Pulmonary Alveolar Proteinosis. 77
Cystic Pattern 77
Definition 77
High-Resolution Computed Tomography Signs 79
Centrilobular Emphysema 81
Langerhans Cell Histiocytosis 81
Laryngotracheobronchial Papillomatosis 82
Lymphangioleiomyomatosis 83
Cystic Metastases 84
Birt-Hogg-Dubé Syndrome 84
Dark Lung Pattern 85
Definition 85
High-Resolution Computed Tomography Signs 85
Chronic Pulmonary Thromboembolism 86
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia 88
Constrictive Bronchiolitis 88
Panlobular Emphysema 89
Swyer-James (MacLeod Syndrome) 89
Imaging of the Solitary Pulmonary Nodule 90
Rationale for the Diagnostic Approach 90
Static Elements 91
Risk Factors 91
Morphologic Aspects 91
Computed Tomography Densitometry 92
Cavitation and Air Bronchogram 92
Dynamic Elements 92
Doubling Time 92
Computed Tomography Contrast Enhancement 93
Positron Emission Tomography Metabolism 93
References 93
Multiple Choice Questions 98.e1
Case 1 98.e2
As a Distorted Fine Net 98.e2
Short History 98.e2
High-Resolution Computed Tomography (eSlide 4.1A,B,C) 98.e2
Histologic Examination (eSlide 4.1D,E) 98.e2
Diagnosis 98.e2
5 Developmental and Pediatric Lung Disease 99
Processing of Pediatric Lung Biopsy Specimens 99
Processing of Pediatric Cystic Lung Lesion Specimens 100
Cysts and Masses 100
Bronchogenic Cysts 100
Bronchial Atresia 101
Pulmonary Sequestration 101
Extralobar Sequestration 102
Intralobar Sequestration 102
Congenital Pulmonary Airway Malformations 103
Pulmonary Interstitial Emphysema 104
Peripheral Cysts Secondary to Lung Maldevelopment 105
Pulmonary Hyperlucency 105
Congenital Lobar Overinflation 105
Polyalveolar Lobe 105
Disorders of Lung Development 106
Acinar Dysplasia 106
Congenital Alveolar Dysplasia 106
Pulmonary Hypoplasia 107
Pulmonary Hyperplasia 107
Vascular Disorders 108
Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins 108
Congenital Pulmonary Lymphangiectasis 108
Diffuse Pulmonary Lymphangiomatosis 110
Pulmonary Arteriovenous Malformations 110
Complications of Prematurity 110
Hyaline Membrane Disease 110
Bronchopulmonary Dysplasia 110
Pediatric Interstitial Lung Disease 111
Alveolar Growth Abnormalities 111
Pulmonary Interstitial Glycogenosis (Infantile Cellular Interstitial Pneumonitis) 113
Genetic Disorders of Surfactant Metabolism 114
Pulmonary Alveolar Proteinosis 114
Chronic Pneumonitis of Infancy 115
Desquamative Interstitial Pneumonia 115
Nonspecific Interstitial Pneumonia 115
Lymphocytic Interstitial Pneumonia and Follicular Bronchiolitis 116
Hypersensitivity Pneumonitis (Extrinsic Allergic Alveolitis) 116
Eosinophilic Pneumonia 116
Aspiration Injury 116
Obliterative Bronchiolitis 120
Neuroendocrine Cell Hyperplasia of Infancy (Persistent Tachypnea of Infancy) 120
Storage Disorders 120
Vascular Disease as a Cause of Interstitial Lung Disease 120
Hemorrhage Syndromes in Children 120
References 121
Multiple Choice Questions 124.e1
Case 1 124.e2
eSlide 5.1 124.e2
Clinical History 124.e2
Virtual Slide Microscopic Findings 124.e2
Diagnosis 124.e2
6 Acute Lung Injury 125
Diffuse Alveolar Damage: The Morphologic Prototype of Acute Lung Injury 125
Specific Causes of Acute Lung Injury 128
Infection 128
Viral Infection 129
Fungal Infection 133
Bacterial Infection 133
Connective Tissue Disease 134
Systemic Lupus Erythematosus 135
Rheumatoid Arthritis 135
Polymyositis/Dermatomyositis 136
Drug Effect 136
Chemotherapeutic Agents 136
Amiodarone 138
Antiinflammatory Drugs 139
Acute Eosinophilic Pneumonia 139
Acute Interstitial Pneumonia 140
Immunologically Mediated Pulmonary Hemorrhage and Vasculitis 140
Radiation Pneumonitis 140
Disease Presenting as Classic Acute Respiratory Distress Syndrome 140
Oxygen Toxicity and Inhalants 141
Shock and Trauma 141
Ingested Toxins 142
Pathologist Approach to the Differential Diagnosis of Acute Lung Injury 142
Clinicopathologic Correlation 143
References 144
Multiple Choice Questions 146.e1
Case 1 146.e2
Diffuse alveolar damage with hyaline membranes (eSlide 6.1) 146.e2
Case 2 146.e2
Acute and fibrinous organizing pneumonia (eSlide 6.2) 146.e2
Case 3 146.e3
Acute lupus pneumonitis (eSlide 6.3) 146.e3
Case 4 146.e3
Amiodarone-induced diffuse alveolar damage (eSlide 6.4) 146.e3
Case 5 146.e3
Acute eosinophilic pneumonia (eSlide 6.5) 146.e3
7 Lung Infections 147
Diagnostic Tools and Strategies 147
Knowledge of the Clinical Setting 148
Pattern Recognition 150
Useful Tissue Stains in Lung Infection 152
Immunologic and Molecular Techniques 153
Limiting Factors in Diagnosis 153
Role of Cytopathologic Examination in Diagnosis of Lung Infection 157
Summary 158
Bacterial Pneumonias 159
Etiologic Agents 159
Histopathology 160
Acute Exudative Pneumonia 160
Nodular/Necrotizing Lesions 160
Miliary Lesions 161
Aspiration Pneumonia and Lung Abscess 161
Chronic Bacterial Pneumonias 162
Bacterial Agents of Bioterrorism 164
Bacillus anthracis 164
Yersinia pestis 165
Francisella tularensis 166
Cytopathology 166
Microbiology 166
Differential Diagnosis 170
Mycobacterial Infections 171
Etiologic Agents 171
Mycobacterium tuberculosis 171
Nontuberculous Mycobacteria 172
Histopathology 172
Primary Tuberculosis 172
Postprimary Tuberculosis 173
Tuberculous Pleurisy 174
Nontuberculous Mycobacterial Infections 174
Cytopathology 176
Microbiology 176
Fungal Pneumonias 178
Etiologic Agents 178
Histopathology 178
Blastomycosis 179
Coccidioidomycosis 180
Histoplasmosis 180
Paracoccidioidomycosis (South American Blastomycosis) 182
Sporotrichosis 182
Penicilliosis 182
Cryptococcosis 184
Candidiasis 185
Aspergillosis 187
Zygomycosis 188
Phaeohyphomycosis 190
Pneumocystosis 191
Cytopathology 193
Cytology of Common Yeast Forms 193
Cytology of Common Mycelial Forms 193
Microbiology 195
Differential Diagnosis 197
Viral Pneumonia 199
Etiologic Agents 199
Histopathology 199
Influenza Virus 199
Parainfluenza Virus 200
Respiratory Syncytial Virus 201
Human Metapneumovirus 201
Measles Virus 201
Hantavirus 202
Coronaviruses 202
Adenovirus 203
Herpes Simplex Viruses 203
Varicella-Zoster Virus 205
Cytomegalovirus 205
Epstein–Barr Virus 205
Cytopathology 206
Microbiology 206
Differential Diagnosis 209
Parasitic Infections 209
Etiologic Agents 209
Histopathology 209
Toxoplasmosis 211
Amebiasis 211
Cryptosporidiosis 211
Microsporidiosis 212
Leishmaniasis 212
Dirofilariasis 212
Strongyloidiasis 213
Echinococcosis 214
Paragonimiasis 214
Schistosomiasis 214
Visceral Larva Migrans 215
Cytopathology 217
Microbiology 217
Differential Diagnosis 218
References 219
Multiple Choice Questions 226.e1
Case 1 226.e5
8 Chronic Diffuse Lung Diseases 227
Idiopathic Interstitial Pneumonias 228
Usual Interstitial Pneumonia 229
Clinical Presentation 230
Radiologic Findings 230
Histopathologic Findings 230
Acute Exacerbation 234
Differential Diagnosis 234
Clinical Course 234
Essential Requirements for Accurate Diagnosis 235
Familial Idiopathic Pulmonary Fibrosis 235
Nonspecific Interstitial Pneumonia 235
Clinical Presentation 236
Radiologic Findings 236
Histopathologic Findings 236
Differential Diagnosis 236
Clinical Course 237
Cryptogenic Organizing Pneumonia 237
Clinical Presentation 238
Radiologic Findings 239
Histopathologic Findings 239
Treatment and Prognosis 239
Differential Diagnosis 239
Respiratory Bronchiolitis–Associated Interstitial Lung Disease 240
Clinical Presentation 240
Radiologic Findings 240
Histopathologic Findings 241
Differential Diagnosis 242
Clinical Course 242
Desquamative Interstitial Pneumonia 242
Clinical Presentation 243
Radiologic Findings 243
Histopathologic Findings 243
Differential Diagnosis 244
Clinical Course 244
Lymphoid Interstitial Pneumonia 244
Clinical Presentation 244
Radiologic Findings 244
Histopathologic Findings 245
Differential Diagnosis 245
9 Nonneoplastic Pathology of the Large and Small Airways 299
Large Airways: Trachea and Bronchi 299
Trachea 299
Tracheobronchial Amyloidosis 299
Tracheobronchomalacia 299
Tracheobronchomegaly 301
Tracheobronchopathia Osteochondroplastica 301
Bronchi 302
Bronchitis 302
Bronchiectasis 302
Middle Lobe Syndrome 303
Small Airways 304
Inflammatory Bronchiolitis 306
Acute Bronchiolitis 306
Acute and Chronic Bronchiolitis 306
Chronic Bronchiolitis 307
Granulomatous Bronchiolitis 308
Bronchiolar Necrosis 312
Respiratory (Smoker’s) Bronchiolitis 312
Peribronchiolar Metaplasia (Lambertosis) 314
Mucostasis 317
Bronchiolar Smooth Muscle Hyperplasia 317
Fibrous Proliferations in and Around Bronchioles 317
Bronchiolitis Obliterans Syndrome 319
Terminal Airway Fibrosis With Dust Deposition (Pneumoconiosis-Associated Small Airway Disease) 320
Dilated and Irregular Bronchiolar Shapes 322
Bronchiolocentric Nodules 322
Clinicopathologic Entities With Prominent Airway Manifestations 323
Asthma-Associated Airway Diseases 323
Allergic Bronchopulmonary Fungal Disease 324
Mucoid Impaction of Bronchi 325
Bronchocentric Granulomatosis 325
Chronic Obstructive Pulmonary Disease 326
Emphysema 326
Neuroendocrine Cell Hyperplasia With Occlusive Bronchiolar Fibrosis (Aguayo-Miller Disease) 327
Diffuse Panbronchiolitis 329
References 330
Multiple-Choice Questions 334.e1
Case 1 334.e2
Clinical History 334.e2
Microscopic Pathology 334.e2
Diagnosis 334.e2
Comment 334.e3
Bibliography 334.e3
Case 2 334.e4
Clinical History 334.e4
Microscopic Pathology 334.e4
Diagnosis 334.e4
Comment 334.e4
Bibliography 334.e5
Case 3 334.e5
Clinical History 334.e5
Microscopic Pathology 334.e5
Diagnosis 334.e5
Comment 334.e6
Bibliography 334.e6
Case 4 334.e6
Clinical History 334.e6
Microscopic Pathology 334.e6
Diagnosis 334.e8
Comment 334.e8
Bibliography 334.e8
Case 5 334.e8
Clinical History 334.e8
Microscopic Pathology 334.e8
Diagnosis 334.e9
Comment 334.e9
Bibliography 334.e9
10 Pneumoconioses 335
Overview and General Considerations 335
Types of Pneumoconiosis 335
Silicosis 335
Clinical Presentation 336
Pathologic Findings 336
Differential Diagnosis 337
Coal Workers’ Pneumoconiosis 339
Clinical Presentation 339
Pathologic Findings 339
Differential Diagnosis 342
Asbestosis 342
Clinical Presentation 342
Pathologic Findings 343
Differential Diagnosis 347
Silicatosis (Silicate Pneumoconiosis) 347
Clinical Presentation 347
Pathologic Findings 347
Differential Diagnosis 348
Talcosis (Talc Pneumoconiosis) 349
Clinical Presentation 349
Pathologic Findings 349
Differential Diagnosis 350
Siderosis 351
Clinical Presentation 351
Pathologic Findings 351
Differential Diagnosis 351
Aluminosis 353
Clinical Presentation 353
Pathologic Findings 353
Differential Diagnosis 354
Hard Metal Lung Disease 354
Clinical Presentation 354
Pathologic Findings 355
Differential Diagnosis 356
Berylliosis 356
Clinical Presentation 356
Pathologic Findings 357
Differential Diagnosis 357
Rare Earth Pneumoconiosis 358
Clinical Presentation 358
Pathologic Findings 358
Differential Diagnosis 358
Other Pneumoconioses 358
References 361
Multiple Choice Questions 364.e1
Case 1 364.e2
eSlide 10.1 364.e2
Case 2 364.e2
eSlide 10.2 364.e2
Case 3 364.e2
eSlide 10.3 364.e2
Case 4 364.e3
eSlide 10.4 364.e3
Case 5 364.e3
eSlide 10.5 364.e3
11 Pulmonary Vasculitis and Pulmonary Hemorrhage 365
Pulmonary Vasculitis 365
Overview of Pulmonary Vasculitis 365
Idiopathic Vasculitic Syndromes That Commonly Affect the Lung 367
Granulomatosis With Polyangiitis (Wegener Granulomatosis) 367
Clinical Features 367
Laboratory Studies 368
Radiologic Features 369
Pathologic Features 369
Differential Diagnosis 374
Diagnosis 377
Treatment and Prognosis 377
Eosinophilic Granulomatosis With Polyangiitis/Churg-Strauss Syndrome 377
Clinical Features 378
Radiologic Features 378
Pathologic Features 379
Differential Diagnosis 379
Treatment and Prognosis 380
Microscopic Polyangiitis 380
Clinical Features 380
Radiographic Features 381
Pathologic Features 381
Differential Diagnosis 381
Treatment and Prognosis 382
Vasculitic Syndromes That Uncommonly Affect the Lung 383
Necrotizing Sarcoid Granulomatosis 383
Clinical Features 383
Radiologic Features 383
Pathologic Features 383
Differential Diagnosis 384
Treatment and Prognosis 384
Giant Cell (Temporal) Arteritis 384
Polyarteritis Nodosa 387
Takayasu Arteritis 387
Clinical Features 387
Radiographic Features 388
Pathologic Features 388
Treatment 388
Behçet Syndrome 388
Clinical Features 388
Radiographic Features 389
Pathologic Features 389
Treatment 389
Secondary Vasculitis 389
Pulmonary Infection and Septic Emboli 389
Classic Sarcoidosis 390
Radiologic Features 390
Pathologic Features 390
Therapy and Prognosis 390
Pulmonary Hemorrhage 390
Clinical View of Pulmonary Hemorrhage 390
Morphologic Approach to Pulmonary Hemorrhage 390
Diffuse Alveolar Hemorrhage 393
Specific Forms of Diffuse Alveolar Hemorrhage 394
Goodpasture Syndrome 394
Granulomatosis With Polyangiitis (Wegener Granulomatosis) 394
Microscopic Polyangiitis 394
Systemic Lupus Erythematosus 394
Idiopathic Pulmonary Hemosiderosis 395
Henoch-Schönlein Purpura (IgA Vasculitis) 395
Isolated Pulmonary Capillaritis 397
References 397
Multiple Choice Questions 400.e1
Case 1 400.e3
Case 2 400.e3
Case 3 400.e4
Case 4 400.e4
Case 5 400.e4
12 Pulmonary Hypertension 401
Morphologic Features of the Pulmonary Vasculature 401
Pulmonary Arteries 401
Pulmonary Veins 402
Bronchial Arteries 402
Recognition of Right Ventricular Hypertrophy 402
Definition of Pulmonary Hypertension 403
Classification of Pulmonary Hypertension 403
Biomarkers of Pulmonary Hypertension 404
Pathologic Features of Pulmonary Hypertension 404
Plexogenic Arteriopathy 404
Clinical and Etiologic Features 404
Imaging Features 404
Morphologic Features 405
Grade I: Muscular Hypertrophy 405
Grade II: Intimal Proliferation 405
Grade III: Concentric Laminar Intimal Fibrosis 405
Grade IV: Necrotizing Vasculitis 405
Grade V: Plexiform Lesions 405
Grade VI: Dilatation and Angiomatoid Lesions 406
Clinical Correlations 406
Differential Diagnosis 407
Thrombotic and Embolic Hypertension 410
Clinical Features 410
Radiologic Features 410
Pathologic Findings 410
Clinical Correlations 413
Differential Diagnosis 413
Pulmonary Venous Hypertension 413
Clinical Features 413
Radiologic Features 414
Pathologic Findings 414
Clinical Correlations 416
Differential Diagnosis 416
Pulmonary Hypertension Secondary to Intrinsic Lung Disease or Hypoxia 416
Morphologic Mimics of Pulmonary Hypertension 417
Pathogenesis and Treatment of Pulmonary Hypertension 417
References 419
Multiple Choice Questions 420.e1
13 Pathology of Lung Transplantation 421
Operation-Related Complications 422
Primary Graft Dysfunction 422
Time Period 422
Clinical Presentation 422
Radiologic Findings 422
Diagnosis 422
Pathologic Findings 422
Histologic Differential Diagnosis 423
Treatment, Prognosis, and Prevention 423
Arterial Anastomotic Obstruction 423
14 Neuroendocrine Neoplasms of the Lung 439
Introduction and General Considerations 440
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia 441
Definitions and Synonyms 441
History 441
Incidence and Demographics 441
Clinical Manifestations 441
Radiologic Features 441
Gross Pathology 441
Microscopic Pathology 441
Special Studies 442
Grading and Staging 442
Differential Diagnosis 442
Genetics 443
Treatment and Prognosis 443
Carcinoid Tumor 443
Definitions and Synonyms 443
Incidence and Demographics 443
Clinical Manifestations 443
Laboratory Findings 443
Radiologic Features 443
Gross Pathology 444
Microscopic Pathology 444
Special Studies 446
Grading and Staging 447
Variants 447
Differential Diagnosis 447
Genetics 447
Treatment and Prognosis 447
Atypical Carcinoid 448
Definitions and Synonyms 448
Incidence and Demographics 448
Clinical Manifestations 448
Laboratory Findings 448
Radiologic Features 448
Gross Pathology 448
Microscopic Pathology 448
Special Studies 449
Grading and Staging 449
Variants 450
Differential Diagnosis 450
Genetics 450
Treatment and Prognosis 450
Large Cell Neuroendocrine Carcinoma 450
Definitions and Synonyms 450
Incidence and Demographics 450
Clinical Manifestations 450
Laboratory Findings 450
Radiologic Features 451
Gross Pathology 451
Microscopic Pathology 451
Special Studies 452
Grading and Staging 452
Variants 452
Differential Diagnosis 452
Genetics 453
Treatment and Prognosis 453
Small Cell Carcinoma 453
Definitions and Synonyms 453
Incidence and Demographics 455
Clinical Manifestations 455
Laboratory Findings 455
Radiologic Features 455
Gross Pathology 455
Microscopic Pathology 455
Combined Type Small Cell Carcinoma 457
Special Studies 457
Grading and Staging 457
Variants 458
Differential Diagnosis 458
Genetics 458
Treatment and Prognosis 459
Primitive Neuroectodermal Tumor 459
Definitions and Synonyms 459
Incidence and Demographics 459
Clinical Manifestations 459
Radiologic Features 459
Gross Pathology 459
Microscopic Pathology 459
Special Studies 459
Differential Diagnosis 459
Genetics 460
Treatment and Prognosis 460
Other Rare Neuroendocrine Tumors 460
References 461
Multiple Choice Questions 466.e1
Case 1 466.e4
eSlide 14.1 466.e4
15 Sarcomas and Sarcomatoid Neoplasms of the Lungs and Pleural Surfaces 467
Part I. Sarcomatoid Carcinoma of the Lung 467
Historical and Terminologic Considerations 467
Clinicopathologic Features of Pulmonary Sarcomatoid Carcinomas 468
Macroscopic Features 468
Histologic Characteristics 468
Homologous Biphasic Sarcomatoid Carcinomas. 469
Heterologous Biphasic Sarcomatoid Carcinomas. 469
Monophasic Sarcomatoid Carcinomas. 469
Special Variants of Sarcomatoid Carcinoma of the Lung 471
Pulmonary Blastoma 471
Pseudoangiosarcomatous (Pseudovascular) Carcinoma 472
Inflammatory Sarcomatoid Carcinoma 472
Pleurotropic (Pseudomesotheliomatous) Sarcomatoid Carcinoma 473
Results of Adjunctive Pathologic Studies 475
Differential Diagnosis of Sarcomatoid Carcinoma 476
Part II: True Primary Sarcomas of the Lung 476
Kaposi Sarcoma 476
Clinical Summary 476
Pathologic Findings 477
Therapy and Prognosis 477
Fibrosarcoma 477
Clinical Summary 478
Pathologic Findings 478
Therapy and Prognosis 479
Primary Pulmonary Hyalinizing Spindle-Cell Tumor With Giant Rosettes. 479
Primary Pulmonary Leiomyosarcoma 479
Clinical Summary 480
Pathologic Findings 480
Therapy and Prognosis 482
Epithelioid Hemangioendothelioma 482
Clinical Summary 482
Pathologic Findings 482
Therapy and Prognosis 485
Hemangiopericytoma and Intrapulmonary Solitary Fibrous Tumor 485
Clinical Summary 485
Pathologic Findings 486
Therapy and Prognosis 487
Malignant Fibrous Histiocytoma 487
Clinical Summary 487
Pathologic Findings 487
Therapy and Prognosis 488
Rhabdomyosarcoma 488
Clinical Summary 488
Pathologic Findings 488
Therapy and Prognosis 489
Chondrosarcoma of the Respiratory Tract 489
Clinical Summary 489
Pathologic Findings 491
Therapy and Prognosis 491
Primary Pulmonary Synovial Sarcoma 491
Clinical Findings 491
Pathologic Findings 494
Therapy and Prognosis 496
Other Primary Pulmonary Sarcomas 496
Part III: Primary Malignant Melanomas of the Lung 497
Clinical Summary 497
Pathologic Findings 497
Therapy and Prognosis 500
Part IV: Sarcomas of the Pulmonary Arterial Trunk 500
Clinical Summary 501
Pathologic Findings 501
Therapy and Prognosis 502
Part V: Tumors of the Pleura 503
Sarcomatoid Malignant Mesothelioma (See Also Chapter 21) 503
Clinical Summary 503
Pathologic Findings 504
Therapy and Prognosis 505
Primary Pleural Sarcomas 506
Pleural Fibrosarcoma and Malignant Solitary Fibrous Tumor 506
Clinical Summary 506
Pathologic Findings 507
Therapy and Prognosis 508
Primary Pleural Leiomyosarcoma 509
Clinical Summary 509
Pathologic Findings 509
Therapy and Prognosis 509
Askin Tumor (Primitive Neuroectodermal Tumor) and Desmoplastic Small Round-Cell Tumor 510
Clinical Summary 510
Pathologic Findings 510
Therapy and Prognosis 512
Pleuropulmonary Blastoma 513
Clinical Summary 514
Pathologic Findings 514
Therapy and Prognosis 516
Vascular Sarcomas of the Pleura 517
References 519
Multiple Choice Questions 526.e1
Case 1 526.e3
eSlide 15.1 526.e3
16 Hematolymphoid Disorders 527
Special Studies 527
Immunohistochemistry 527
Indications 527
17 Nonneuroendocrine Carcinomas (Excluding Sarcomatoid Carcinoma) and Salivary Gland Analogue Tumors of the Lung 573
Incidence 573
Demographics 573
Prognosis 573
Etiology 573
Lung Cancer Clinical Findings and Imaging 574
Clinical Findings 574
Imaging 574
Lung Cancer Staging, Prognosis, and Traditional Therapy 574
Staging 574
Prognosis 575
Traditional Therapy 575
Lung Cancer Histology 575
Overview of Lung Cancer Histology 575
2015 World Health Organization Classification of Lung Cancer 575
Adenocarcinoma 576
Lepidic Pattern and Bronchioloalveolar Carcinoma 576
Atypical Adenomatous Hyperplasia 577
Adenocarcinoma in situ 577
Minimally Invasive Adenocarcinoma 578
Invasive Adenocarcinoma 578
Lepidic Adenocarcinoma 578
Acinar Adenocarcinoma 579
Papillary Adenocarcinoma 579
Micropapillary Adenocarcinoma 579
Solid Adenocarcinoma 579
Invasive Mucinous Adenocarcinoma 579
Colloid Adenocarcinoma 580
Fetal Adenocarcinoma 580
Enteric Adenocarcinoma 581
Signet Ring and Clear Cell Features 581
Squamous Cell Carcinoma 581
Adenosquamous Carcinoma 583
Large Cell Carcinoma 583
Minor Cell Types (Including Salivary Gland and Sarcomatoid Types) 584
Sarcomatoid Type. 584
Carcinosarcoma. 584
Blastoma. 584
Pleomorphic Carcinoma. 584
Salivary Gland Type. 585
Adenoid Cystic Carcinoma. 585
Mucoepidermoid Carcinoma. 585
Epithelial-Myoepithelial Carcinoma. 586
Lymphoepithelioma-Like Carcinoma. 586
Nuclear Protein in Testis Carcinoma. 586
Cytology 586
Adenocarcinoma 587
Squamous Cell Carcinoma 588
Salivary Gland-Like Tumors 591
Other Neoplasms 592
Targeted Therapy Biomarkers in Lung Cancer 592
Immune Checkpoint Therapies in Lung Cancer 592
References 593
Multiple Choice Questions 596.e1
Case 1: Pulmonary Adenocarcinoma Carcinoma 596.e3
eSlide 17.1 596.e3
18 Metastatic Tumors in the Lung 597
Routes of Spread for Intrapulmonary Metastases 597
Vascular Metastases 597
Lymphogenous Metastases 599
Direct Seeding 600
Pleural Metastases 600
Endobronchial Metastases 601
Modalities for the Diagnosis of Pleuropulmonary Metastases 603
Practical Approach to Differential Diagnosis 604
Adenocarcinoma Variants 606
Papillary Adenocarcinomas 606
Clear Cell Adenocarcinomas 607
Signet-Ring Cell Adenocarcinomas 609
Well-Differentiated Adenocarcinomas 609
Oncocytic and Granular Cell Carcinomas 612
Largely Necrotic Adenocarcinomas 614
Mucinous Adenocarcinomas 614
Other Metastatic Malignancies That Mimic Adenocarcinomas of the Lung 616
Malignant Small Round Cell Tumors 621
Squamous Cell Carcinomas and Morphologic Simulants 623
Undifferentiated Large Polygonal Cell Malignancies 627
Other Adjunctive Pathologic Techniques for the Diagnosis of Metastatic Carcinoma 629
Outcomes Analysis 633
References 639
Multiple Choice Questions 642.e1
19 Pseudoneoplastic Lesions of the Lungs and Pleural Surfaces 643
Pulmonary Hamartoma 643
Inflammatory Pseudotumor—Plasma Cell Granuloma of the Lung 646
Mycobacterial Spindle-Cell Pseudotumor 649
Pseudoneoplastic Hematolymphoid Processes 650
Rosai-Dorfman Disease (Sinus Histiocytosis With Massive Lymphadenopathy) 650
Extramedullary Hematopoiesis 651
Pseudoneoplastic Changes as a Consequence of Lung Injury 653
Peribronchiolar Metaplasia (Lambertosis) 654
Pseudoneoplastic Lesions of the Pleural Surfaces 655
Reactive Mesothelial Proliferations 656
Tumefactive Hyaline Pleural Plaques 658
Diffuse Pleural Fibrosis 659
References 660
Multiple Choice Questions 664.e1
Case 1 664.e3
eSlide 19.1 664.e3
20 Benign and Borderline Tumors of the Lungs and Pleura 665
Benign Pleuropulmonary Neoplasms 665
Clinical Features 665
Benign Tumors That Are Principally Tracheal and Endobronchial 666
Solitary Tracheobronchial Papilloma 666
Multifocal Respiratory Tract Papillomatosis 667
Bronchial Mucous Gland Adenoma 668
Salivary Gland Analog Tumors 671
Mixed Tumor (Pleomorphic Adenoma) 671
Oncocytoma 671
Peripheral Nerve Sheath Tumors 674
Granular Cell Tumors 677
Benign Lesions Affecting Either the Airways or the Lung Parenchyma 679
Alveolar Adenoma 679
Papillary Adenoma 681
Leiomyoma 681
Glomus Tumor and Glomangioma 681
Chondroma, Myxoma, and Fibromyxoma 685
Solitary Pulmonary Hemangioma and Hemangiomatosis 685
Lipoma and Lipoblastoma 686
Angiomyolipoma 688
Myelolipoma 689
Benign Tumors of the Pleura 689
Adenomatoid Tumor 689
Calcifying Fibrous Pseudotumor 691
Leiomyoma 692
Biologically Borderline Tumors of the Lung and Pleura 692
Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) 692
Sclerosing Hemangioma (Pneumocytoma) 695
Pulmonary Mucinous Cystadenoma and Borderline Mucinous Tumor 698
Solitary Fibrous Tumor 700
Desmoid Tumor 703
Clear Cell Tumor 705
Primary Pleuropulmonary Thymoma 705
Heterotopic Meningeal Proliferations 710
Intrapulmonary Teratomas 713
Cystic Fibrohistiocytic Tumor of the Lung 714
Other Lesions 715
References 715
Multiple Choice Questions 722.e1
Case 1 722.e2
eSlide 20.1 722.e2
21 Malignant and Borderline Mesothelial Tumors of the Pleura 723
Malignant Mesothelioma 723
Clinical Findings in Pleural Mesothelioma 723
Etiologic Considerations in Pleural Mesothelioma 725
Gross Features of Pleural Mesothelioma 727
Cytopathologic Features of Pleural Mesothelioma 727
Histopathologic Features of Pleural Mesothelioma 730
Epithelioid Mesothelioma 731
Sarcomatoid (Spindle Cell) Mesothelioma 732
Desmoplastic Mesothelioma 733
Biphasic Mesothelioma 736
Small Cell Mesothelioma 736
Rhabdoid Mesothelioma 736
Localized (Solitary) Mesothelioma 737
Histochemical Features of Pleural Mesothelioma 737
Electron Microscopic Features of Pleural Mesothelioma 738
Immunohistochemical Findings in Pleural Mesothelioma 739
Antibodies Often Used in the Analysis of Possible Mesothelioma 741
General and Exclusionary Markers 741
Keratins. 741
Epithelial Membrane Antigen. 741
Carcinoembryonic Antigen. 741
Thyroid Transcription Factor-1. 742
Napsin-A. 742
CD15. 742
CA 72-4. 742
Ber-Ep4. 742
MOC-31. 742
BG8. 742
p53. 742
Inclusionary Markers 742
Calretinin. 742
WT1 Gene Product. 742
Thrombomodulin. 743
Podoplanin. 743
Other Markers 744
Oncofetal Proteins. 744
Blood Group Isoantigens. 744
Mesothelin. 744
HBME-1 and Cancer Antigen 125. 744
Neuroendocrine Determinants. 744
Additional Hematopoietic Markers. 744
Anti-BAP-1, p16, and Other Supplementary Reagents. 745
Practical Points Regarding the Immunohistochemistry of Mesothelioma 745
Cytogenetic and Molecular Features of Pleural Mesothelioma 745
Differential Diagnosis of Pleural Mesothelioma: Special Considerations 746
Differential Diagnosis of Benign Versus Malignant Mesothelial Proliferations 746
Florid Mesothelial Hyperplasia Versus Epithelioid Mesothelioma. 746
Fibrohyaline Pleuritis Versus Desmoplastic Mesothelioma. 746
Differential Diagnosis of Cytologically Malignant Pleural Neoplasms 747
Epithelioid Mesothelioma Versus Hematopoietic Malignancies. 747
Epithelioid Mesothelioma Versus Epithelioid Endothelial Neoplasms. 748
Primary Pleural Myxoid Chondrosarcoma Versus Mesothelioma. 748
Synovial Sarcoma Versus Mesothelioma. 749
Pseudomesotheliomatous Sarcomatoid Carcinoma Versus Mesothelioma. 749
Small Cell Mesothelioma Versus Other Small Cell Malignancies. 750
Primary Pleural Thymomatosis Versus Mesothelioma. 750
Solitary Fibrous Tumor of the Pleura Versus Sarcomatoid Mesothelioma. 751
Clear Cell Mesothelioma Versus Metastatic Renal Cell Carcinoma. 751
Oncocytoid/Deciduoid Mesothelioma Versus Other “Pink” Cell Malignancies. 751
Rhabdoid Mesothelioma Versus Metastases of Extrarenal Malignant Rhabdoid Tumors. 752
Epithelioid Mesothelioma Versus Primary or Metastatic Germ Cell Malignancies. 752
Metastatic Intranodal Mesothelioma Versus Lymph Nodal Mesothelial Rests. 752
Borderline (Low-Grade Malignant) Mesothelial Tumors 752
Etiologic Considerations 753
Clinical Findings 753
Pathologic Observations 753
Staging and Prognosis of Malignant Mesothelioma 754
References 755
Multiple Choice Questions 762.e1
Case 1 762.e3
eSlide 21.1 762.e3
Case 2 762.e3
eSlide 21.2 762.e3
Case 3 762.e3
eSlide 21.3 762.e3
Case 4 762.e3
eSlide 21.4 762.e3
Case 5 762.e3
eSlide 21.5 762.e3
Appendix: Miscellaneous Distinctive Histopathologic Findings 763
Index 781
A 781
B 784
C 785
D 789
E 790
F 791
G 792
H 793
I 794
K 796
L 796
M 798
N 800
O 802
P 802
R 807
S 807
T 810
U 811
V 811
W 811
X 811
Y 811
Z 811
Inside Back Cover ibc1